James E. Wagner Cultivation Corporation announce that it has received a licence amendment from Health Canada for the sale of cannabis extracts, edibles and topicals at its pilot facility (“JWC1”) located at 855 Trillium Drive in Kitchener, Ontario. The approval is an important development for c, as it remains on track to introduce its derivative line of cannabis extract products in the first quarter of 2020. The product roster is expected to include kief, rosins, and pre-rolls in various quantity formats. Health Canada as well has approved a facility reconfiguration application for a portion of JWC1. One of the JWC1 growing rooms of approximately 1,200 square feet will be converted from cultivation use to processing use. This will allow JWC to engage in processing and production of the product roster of extracts that it will add to its product line. As a result of the approved facility reconfiguration, cultivation space at JWC1 is expected to decrease its production capacity of cannabis flower by approximately 250 kg per year. This decrease is not expected to have a material impact on the Corporation’s financial performance or previously announced forward guidance. The financial performance of the Corporation will be improved by the increased ability for production of its expanded product lines and the processing of those products into sales.